GC Green Cross MS Obtains Export Approval for Dengue Fever Rapid Diagnostic Kit

GC Green Cross MS announced on the 18th that it has obtained export approval from the Ministry of Food and Drug Safety for the dengue virus rapid diagnostic kit 'GENEDIA W Dengue NS1 Ag' antigen test and 'GENEDIA W Dengue IgM/IgG Ab' antibody test.

GC Green Cross MS Dengue Virus Diagnostic Kit (Antigen). [Photo by GC Green Cross MS]

The dengue diagnostic kit developed by GC Green Cross MS this time applies a principle similar to that of the COVID-19 rapid diagnostic kit. It can diagnose dengue within 20 minutes through blood specimens and can detect all four dengue virus serotypes. The company explained that clinical specimen tests secured internally confirmed higher sensitivity and accuracy compared to other companies.

Dengue fever is a representative viral febrile illness transmitted by the Aedes aegypti mosquito, mainly in tropical and subtropical regions, similar to the Zika virus. It requires differential diagnosis as its symptoms are similar to other mosquito-borne diseases such as chikungunya. Recently, with global warming and accelerated climate change, the risk of mosquito-borne disease transmission has increased internationally, raising the importance of quarantine and diagnosis.

A GC Green Cross MS official stated, "Amid the rapid increase in global infections due to the spread of the mosquito-borne dengue virus mainly in Southeast Asia and South America, we expect rapid sales expansion in the mosquito-borne infectious virus diagnostic kit market with this export approval." He added, "Follow-up product development for mosquito-borne infectious diseases other than dengue fever is underway."

This content was produced with the assistance of AI translation services.